Bioscience

UC Cancer Center elected to elite group of global cancer treatment and research institutions

UC Cancer Center elected to elite group of global cancer treatment and research institutions

AURORA - University of Colorado Cancer Center is the newest addition to an elite group of cancer centers across the globe, CU announced. The CU Cancer Center was elected to the National... Read More

By: Steve Monday March 25, 2013 0 comments Tags: Aurora, Dan Theodorescu

BioBoot Camp 2013 set for April 18-19, deadline to apply is April 3

BioBoot Camp 2013 set for April 18-19, deadline to apply is April 3

DENVER - Colorado BioScience Association will present BioBoot Camp 2013 , a free workshop for life science startup companies, on April 18-19 in Denver. Deadline to apply for the camp by... Read More

By: Steve Friday March 22, 2013 0 comments Tags: BioBoot Camp 2013, Denver, Dorsey and Whitney

CID4 seeks next portfolio company by April 2

CID4 seeks next portfolio company by April 2

AURORA - The Colorado Institute for Drug, Device and Diagnostic Development (CID4) is seeking its next portfolio life science company to help with mentoring and funding assistance, CID4... Read More

By: Steve Thursday March 21, 2013 0 comments Tags: Aurora, CID4, Kevin M. Smith, portfolio companies

Venaxis expands European distribution network for APPY1 appendicitis test

Venaxis expands European distribution network for APPY1 appendicitis test

CASTLE ROCK - Venaxis Inc . (Nasdaq: APPY), an in vitro diagnostic company focused on gaining FDA approval and commercialization of its APPY1 appendicitis test, announced it has signed... Read More

By: Steve Tuesday March 19, 2013 0 comments Tags: APPY1, Castle Rock, Don Hurd, EMELCA Bioscience, Venaxis

University of Colorado licenses dental polymer technology to 3M

University of Colorado licenses dental polymer technology to 3M

BOULDER - An advanced polymer technology developed at the University of Colorado-Boulder has been licensed to 3M. The licensed technology, developed by a team of researchers led by CU-Boulder... Read More

By: Steve Monday March 18, 2013 0 comments Tags: 3M, Boulder, Christopher Bowman, MaryBeth Velequette

Omni Bio announces favorable results in its lead recombinant molecule

Omni Bio announces favorable results in its lead recombinant molecule

DENVER - Omni Bio Pharmaceutical Inc. (OTCBB: OMBP), a pharmaceutical company focused on commercializing new uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of medical... Read More

By: Steve Monday March 18, 2013 0 comments Tags: AAT, Bruce Schneider, Denver, Fc-AAT

CU Cancer Center testing new drug to treat mouth sores from cancer radiation treatment

CU Cancer Center testing new drug to treat mouth sores from cancer radiation treatment

AURORA - The University of Colorado Cancer Center said it is testing a promising new drug to treat and protect against mouth sores commonly associated with cancer treatment. A CU Cancer... Read More

By: Steve Monday March 18, 2013 0 comments Tags: Aurora, Smad 7, Xiao-Jing Wang